Assembly Biosciences Inc

NASDAQ:ASMB   9:47:48 AM EDT
18.48
+0.36 (+1.99%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)141.15M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$5.3 Million
Adjusted EPS-$1.73
See more estimates
10-Day MA$17.47
50-Day MA$14.33
200-Day MA$14.38
See more pivots

Assembly Biosciences Inc Stock, NASDAQ:ASMB

Two Tower Place, 7th floor, South San Francisco, California 94080
United States of America
Phone: +1.833.509.4583
Number of Employees: 65

Description

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses on two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.